Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
METEORA CAPITAL, LLC OCAX OCA Acquisition Corp. Class A Common Stock 13G 9.74% 2y
Bpifrance Participations S.A. STM STMicroelectronics N.V. 13G/A 28.2% 2y
ARISTEIA CAPITAL, L.L.C. SCRM Screaming Eagle Acquisition Corp. Class A Ordinary Shares 13G/A 9.79% 2y
Rock Springs Capital Management LP ACRS Aclaris Therapeutics, Inc. 13G/A 4.23% 2y
Select Equity Group, L.P. SGI Somnigroup International Inc. 13G/A 13.2% 2y
RTW INVESTMENTS, LP TARS Tarsus Pharmaceuticals, Inc. 13G/A 9.5% 2y
GLAZER CAPITAL, LLC SMNR Semnur Pharmaceuticals, Inc. 13G 6.85% 2y
Deep Track Capital, LP PLRX Pliant Therapeutics, Inc. 13G/A 9.6% 2y
T. Rowe Price Investment Management, Inc. PRAA Pra Group Inc 13G 6.9% 2y
Atalaya Capital Management LP SHFS SHF Holdings, Inc. 13G/A 3.25% 2y
CITADEL ADVISORS LLC ACRO Acropolis Infrastructure Acquisition Corp. 13G/A 0% 2y
Kynam Capital Management, LP CLDX Celldex Therapeutics, Inc. 13G 5.5% 2y
AQR CAPITAL MANAGEMENT LLC RCAC Revelstone Capital Acquisition Corp. Class A Common Stock 13G/A 1.87% 2y
Suzano Holding S.A. SUZ Suzano S.A. 13G/A 45% 2y
Phoenix Venture Partners II, LP ABSI Absci Corp 13G/A 15.5% 2y
Forager Fund, L.P. MCFT MasterCraft Boat Holdings, Inc. 13G/A 5.5% 2y
Lincoln Park Capital Fund, LLC CLRB Cellectar Biosciences, Inc. 13G/A 9.68% 2y
Long Focus Capital Management, LLC ONIT Onity Group Inc. 13G/A 8.5% 2y
Fourthstone LLC CCNB Coastal Carolina Bancshares, Inc. 13G/A 7.94% 2y
AWM Investment Company, Inc. GNSS Genasys Inc. 13G/A 13.1% 2y
Shaolin Capital Management LLC DSAQ Direct Selling Acquisition Corp. 13G/A 5.09% 2y
SOROS FUND MANAGEMENT LLC LUCK Lucky Strike Entertainment Corp 13G/A 0% 2y
Nantahala Capital Management, LLC CDXS Codexis, Inc. 13G/A 6.6% 2y
T. Rowe Price Investment Management, Inc. HAYN Haynes International, Inc. 13G/A 11.5% 2y
ARMISTICE CAPITAL, LLC NVIV InVivo Therapeutics Holdings Corp 13G/A 4.99% 2y
PRICE T ROWE ASSOCIATES INC /MD/ WING Wingstop Inc. 13G/A 7.4% 2y
AWM Investment Company, Inc. NMTC NEUROONE MEDICAL TECHNOLOGIES Corp 13G/A 9.8% 2y
Avoro Capital Advisors LLC MDGL Madrigal Pharmaceuticals, Inc. 13G/A 9.9% 2y
Deep Track Capital, LP AMAM Ambrx Biopharma, Inc. Common Stock 13G/A 5.88% 2y
BIOTECHNOLOGY VALUE FUND L P VRDN Viridian Therapeutics, Inc.DE 13G/A 0% 2y
Lytton, Laurence W. GIGA Giga-Tronics Inc 13G/A 9.99% 2y
ARMISTICE CAPITAL, LLC TLPH Talphera, Inc. 13G/A 4.99% 2y
Radcliffe Capital Management, L.P. HWKZ Hawks Acquisition Corp 13G/A 0% 2y
ARISTEIA CAPITAL, L.L.C. SVII Spring Valley Acquisition Corp. II Class A Ordinary Shares 13G 5.34% 2y
Empyrean Capital Partners, LP OKLO Oklo Inc. 13G/A 9.99% 2y
Westchester Capital Management, LLC TRTL TortoiseEcofin Acquisition Corp. III 13G 9.19% 2y
Charles Mosseri Marlio XAIR Beyond Air, Inc. 13G/A 9.21% 2y
Commodore Capital LP CELC Celcuity Inc. 13G/A 9.9% 2y
Point72 Asset Management, L.P. AVTX Avalo Therapeutics, Inc. 13G/A 0.3% 2y
RBC Global Asset Management Inc. UNTC UNIT CORP 13G/A 0% 2y
L. Lowry Baldwin BWIN Baldwin Insurance Group, Inc. 13G/A 25.4% 2y
PRICE T ROWE ASSOCIATES INC /MD/ CCCC C4 Therapeutics, Inc. 13G/A 5.2% 2y
ARMISTICE CAPITAL, LLC APLT Applied Therapeutics, Inc. Common Stock 13G/A 0% 2y
NOMURA HOLDINGS INC M Macy's, Inc. 13G 5.6% 2y
BAKER BROS. ADVISORS LP SYRE Spyre Therapeutics, Inc. 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. PRCT PROCEPT BioRobotics Corp 13G 7.3% 2y
David Barrett, individually and as trustee of the Barrett Family Trust, solely in such trust's capacity as the controlling member of Barrett Trust LLC EXFY Expensify, Inc. 13G/A 7.1% 2y
Alger Associates, Inc. 13-3017981 CWAN Clearwater Analytics Holdings, Inc. 13G/A 2.8% 2y
PRICE T ROWE ASSOCIATES INC /MD/ XMTR Xometry, Inc. 13G/A 6% 2y
BAKER BROS. ADVISORS LP ABCL AbCellera Biologics Inc. 13G 7.9% 2y